ClinVar Miner

Submissions for variant NM_006231.4(POLE):c.6675C>T (p.Arg2225=)

gnomAD frequency: 0.00125  dbSNP: rs149973644
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 17
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000679670 SCV000261717 benign not provided 2025-02-04 criteria provided, single submitter clinical testing
GeneDx RCV000679670 SCV000520975 likely benign not provided 2020-07-27 criteria provided, single submitter clinical testing
Ambry Genetics RCV000565304 SCV000671241 likely benign Hereditary cancer-predisposing syndrome 2015-06-19 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PreventionGenetics, part of Exact Sciences RCV000679670 SCV000806847 likely benign not provided 2017-05-09 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000425210 SCV000888570 benign not specified 2017-06-09 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000679670 SCV001148866 likely benign not provided 2025-02-01 criteria provided, single submitter clinical testing POLE: BP4, BP7
Genetic Services Laboratory, University of Chicago RCV000425210 SCV002066433 likely benign not specified 2021-11-22 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000565304 SCV002536925 benign Hereditary cancer-predisposing syndrome 2020-09-16 criteria provided, single submitter curation
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000425210 SCV002548401 benign not specified 2022-05-05 criteria provided, single submitter clinical testing
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000425210 SCV002550018 likely benign not specified 2025-03-04 criteria provided, single submitter clinical testing
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV001080214 SCV004016720 benign Colorectal cancer, susceptibility to, 12 2023-07-07 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000679670 SCV004562288 likely benign not provided 2023-03-24 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV000679670 SCV005217301 likely benign not provided criteria provided, single submitter not provided
Genome Diagnostics Laboratory, Amsterdam University Medical Center RCV000679670 SCV001809631 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000425210 SCV001926063 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000679670 SCV001959861 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000679670 SCV001973086 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.